Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.22 | 1.67 |
NAV | ₹15.74 | ₹219.65 |
Fund Started | 12 Jul 2022 | 20 Aug 2004 |
Fund Size | ₹894.15 Cr | ₹17226.97 Cr |
Exit Load | Exit load of 1%, if redeemed within 90 days. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 10.45% | 15.44% |
3 Year | - | 24.73% |
5 Year | - | 31.38% |
1 Year
3 Year
5 Year
Equity | 94.28% | 83.37% |
Cash | 4.27% | 16.33% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.15% |
ICICI Bank Ltd. | 7.93% |
Larsen & Toubro Ltd. | 5.83% |
Reliance Industries Ltd. | 5.04% |
Persistent Systems Ltd. | 4.67% |
Titan Company Ltd. | 4.42% |
Sun Pharmaceutical Industries Ltd. | 4.36% |
Infosys Ltd. | 4.14% |
Marico Ltd. | 4.09% |
Shriram Finance Ltd | 4.08% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.34% |
ICICI Bank Ltd. | 9.00% |
Axis Bank Ltd. | 8.70% |
Kotak Mahindra Bank Ltd. | 4.41% |
Maruti Suzuki India Ltd. | 4.18% |
SBI Life Insurance Company Ltd. | 4.04% |
Cipla Ltd. | 3.77% |
HCL Technologies Ltd. | 3.70% |
Bharti Airtel Ltd. | 3.22% |
Piramal Pharma Ltd. | 3.00% |
Name | Trideep Bhattacharya | Dhruv Muchhal |
Start Date | 01 Oct 2021 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing in equity and equity related instruments of upto 30 companies across market capitalisation. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 12 Jul 2022 | 20 Aug 2004 |
Description
Launch Date